Cargando…

Further Challenges

Detalles Bibliográficos
Autor principal:	Jirles, B
Formato:	Texto
Lenguaje:	English
Publicado:	National Institute of Environmental Health Science 2000
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556948/ https://www.ncbi.nlm.nih.gov/pubmed/11185380

Ejemplares similares

Probiotic as anti-colorectal cancer agents: Challenges and further perspective
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Further Research on Epidemic Dropsy
por: Lal, R. B.
Publicado: (1937)

Further Education of Medical Licentiates
por: Biswas, S. S.
Publicado: (1949)

Further Success with Potassii Nitras
por: Cock, L. W.
Publicado: (1890)

Further Comments on the Bioavailability of D4
por: Andersen, ME
Publicado: (2002)

Undertaking Research in Other Countries: Further Considerations
por: Muula, Adamson
Publicado: (2007)

Further discussion on glucocorticoid treatment of COVID-19
por: Feng, Yun’ai, et al.
Publicado: (2022)

Further Advantages of a Unique Author Identification Number
por: Joly, Etienne
Publicado: (2006)

Further defining and conceptualizing opioid misuse in chronic pain
por: Voon, Pauline
Publicado: (2015)

Further available immunization option to prevent pneumococcal disease
por: Vojtek, Ivo, et al.
Publicado: (2015)

Further Success with Nitre as a Remedy in Chill and Fever
por: Hunter, J. D.
Publicado: (1890)

DIABRISK-SL trial: further consideration of age and impact of imputations
por: Gkioni, Efstathia, et al.
Publicado: (2019)

Neonatal care practices need to be further explored – Authors' reply
por: Sacks, Emma, et al.
Publicado: (2021)

Radiation Port Cutaneous Metastases: A Further Example of Immunocompromised District
por: Ruocco, Eleonora, et al.
Publicado: (2014)

Beneficiality of combined levetiracetam, clonazepam for myoclonus in MERRF requires further confirmation
por: Finsterer, Josef
Publicado: (2019)

“Do no further harm” – Why shall we sedate unresponsive patients?
por: Kalbhenn, Johannes, et al.
Publicado: (2021)

A close view of the Hepatitis C virus vaccines with further perspective
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Still Stratus Not Altocumulus: Further Evidence against the Date/Party Hub Distinction
por: Batada, Nizar N, et al.
Publicado: (2007)

Middle East Respiratory Syndrome and Blood Donation: Topic for Further Study and Discussion
por: Wiwanitkit, Viroj
Publicado: (2014)

Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data
por: Chen, James J, et al.
Publicado: (2007)

Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: Helgeson, Scott A., et al.
Publicado: (2022)

India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Lead in drinking water: a preventive solution.
por: Jirles, B, et al.
Publicado: (1997)

Applying comprehensive histologic assessment and genetic testing to synchronous multifocal lung adenocarcinomas and further survival analysis
por: Xiao, Fei, et al.
Publicado: (2019)

Integration of palliative care approach into community mental health service may further reduce emergency admissions
por: Chan, Kwok Ying, et al.
Publicado: (2023)

Investigating the potential link between lunar cycle and multiple sclerosis relapses: a call for further studies
por: Yousfi, Narimen, et al.
Publicado: (2023)

Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
por: Jian, Fanchong, et al.
Publicado: (2022)

A proposal for further developing fatigue-related post COVID-19 health states for burden of disease studies
por: Wyper, Grant M. A., et al.
Publicado: (2023)

Furthering patient adherence: A position paper of the international expert forum on patient adherence based on an internet forum discussion
por: van Dulmen, Sandra, et al.
Publicado: (2008)

Regarding distance of residence in 1984 may be used as exposure surrogate for the Bhopal disaster - further observations on post-disaster epidemiology
por: Dhara, V. Ramana, et al.
Publicado: (2013)

Reply to Helgeson et al.: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: LaPatra, Tess, et al.
Publicado: (2022)

A Further Response to Shah Ebrahim
por: Makover, Michael
Publicado: (2005)

Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies?
por: Corvec, Stéphane, et al.
Publicado: (2016)

DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation
por: Rolles, Benjamin, et al.
Publicado: (2023)

Safety and efficacy concerns of long-acting GnRHa trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
por: Ingold, C., et al.
Publicado: (2023)

Challenging the paradigm
por: Everard, Mark L.
Publicado: (2022)

Reducing the incidence of predictors of cardio-metabolic disease and dysglycaemia with lifestyle modification in at-risk persons – results of further analyses of DIABRISK-SL in those below 18 years of age
por: Fountoulakis, Nikolaos, et al.
Publicado: (2019)

Omicron: a challenge to hybrid immunity – correspondence
por: Niranjan, Ankush K., et al.
Publicado: (2023)

Re: Safety and efficacy concerns of long-acting GnRH agonist trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
por: Massarotti, C., et al.
Publicado: (2023)

Reply to: Challenging the paradigm
por: Bush, Andrew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sdkvf9djkmtht1s35efmlm40b1